Your browser doesn't support javascript.
loading
Identification and pharmacokinetics of multiple constituents in rat plasma after oral administration of Yinchenzhufu decoction.
Wang, Qian; Jiang, Peng; Ye, Fu-Yuan; Shi, Rong; Ma, Yue-Ming; Zhong, Jie; Wu, Jia-Sheng; Liu, Ping; Liu, Cheng-Hai; Jia, Yi-Qun.
Affiliation
  • Wang Q; Department of Pharmacology, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
  • Jiang P; Department of Pharmacology, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
  • Ye FY; Instrumental Analysis Center, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
  • Shi R; Department of Pharmacology, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
  • Ma YM; Department of Pharmacology, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China. Electronic address: mayueming_117@hotmail.com.
  • Zhong J; Department of Pharmacology, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
  • Wu JS; Department of Pharmacology, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
  • Liu P; Key Laboratory of Liver and Kidney Diseases (Ministry of Education), Institute of Liver Diseases, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
  • Liu CH; Key Laboratory of Liver and Kidney Diseases (Ministry of Education), Institute of Liver Diseases, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
  • Jia YQ; Instrumental Analysis Center, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
J Ethnopharmacol ; 153(3): 714-24, 2014 May 14.
Article in En | MEDLINE | ID: mdl-24704592
ABSTRACT
ETHNOPHARMACOLOGICAL RELEVANCE Yinchenzhufu decoction (YCZFD) is a classical Chinese herbal formula and has been used to treat severe jaundice in chronic liver injuries since the Qing Dynasty (18th century CE). To identify the components absorbed into the blood in YCZFD and explore their pharmacokinetic profile for understanding the effective ingredients of YCZFD. MATERIALS AND

METHODS:

After rats were given YCZFD by intragastric administration, the plasma was processed by precipitation of protein. The compounds in YCZFD extract and the plasma were identified by using high-resolution mass spectrometry with a database-directed strategy. The pharmacokinetics of multiple compounds from YCZFD in rat plasma was studied by using the established UPLC-MS/MS method.

RESULTS:

Forty compounds in YCZFD extract and 21 prototype compounds with 11 metabolites in rat plasma were detected after oral administration. The pharmacokinetic parameters of glycyrrhizic acid, glycyrrhetic acid, cinnamic acid, ononin, atractylenolide III, and liquiritin from YCZFD were obtained in rats.

CONCLUSIONS:

The identified constituents and the pharmacokinetic features of YCZFD are helpful for understanding the material bases of its therapeutic effects.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drugs, Chinese Herbal Type of study: Diagnostic_studies Limits: Animals Language: En Journal: J Ethnopharmacol Year: 2014 Document type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drugs, Chinese Herbal Type of study: Diagnostic_studies Limits: Animals Language: En Journal: J Ethnopharmacol Year: 2014 Document type: Article Affiliation country: China